Disease | prostate cancer |
Phenotype | C0026764|myeloma |
Sentences | 3 |
PubMedID- 25737876 | Bisphosphonates are group of drugs that inhibit bone resorption and are used to treat a range of pathologies including paget's disease, osteoporosis, multiple myeloma and metastasis associated with breast or prostate cancer. |
PubMedID- 19767707 | Bisphosphonates inhibit bone resorption and are used to treat a range of pathologies, including paget disease, osteoporosis, multiple myeloma and metastases associated with breast or prostate cancer. |
PubMedID- 25897322 | It has amongst others been attributed with malignant skull base lesions such as multiple myeloma [3], matastasis of prostate cancer [4,5], internal carotid dissection [6,7], hypoglossal schwannoma [8] and jefferson fracture [9,10]. |
Page: 1